Industry expert speakers at our Pharma IQ events include:

  • Dr. YK Gupta
    Coordinator,Pharmacovigilance Programme of India
    Professor and Head, Department of Pharmacology All India Institute of Medical Sciences (AIIMS)
  • Eisah A. Rahman
    Senior Deputy Director, Pharmaceutical Services – Enforcement, Ministry of Health National Pharmaceutical Control Bureau
    Chair
    ASEAN – Pharmaceutical Product Working Group
  • Shirley Ramesh
    Senior Officer, Standards and Conformance Unit, Trade and Facilitation Division, Market Integration Directorate
    ASEAN Economic Community Department, ASEAN Secretariat
  • Dr. Cynthia Diza
    Medical Specialist III
    Officer-in-charge, Adverse Drug Reactions Unit
    Philippines Food and Drug Administration

Bridging the gap in drug safety and pharmacovigilance practices within Asia and safeguarding consumers’ health

Pharmacovigilance Asia 2010 – Asia’s 1st ever regional conference focusing on pharmacovigilance and drug safety!

Pharmacovigilance and drug safety management in Asia are rapidly gaining attention in Asia with the shift of pharmaceutical activities from west to east. With an increasing number of clinical trials being held in the region and the rapidly growing markets for both pharmaceutical products and medical devices, the risk of ADEs/ADRs/SAEs has never been greater.

Every pharmaceutical/medical device company must address and manage drug safety risks and pharmacovigilance if they want to sustain the public’s confidence.

Are you taking the necessary steps to effectively manage pharmacovigilance and drug safety?

The Pharmacovigilance Asia 2010 held in Singapore on 26-27 October 2010 is a one of a kind event which will bring you PV regulatory updates from across Asia, and experts in pharmacovigilance and drug safety from pharmaceutical/biotech and CROs will discuss the most pressing issues faced in drug safety.

Key themes for Pharmacovigilance Asia 2010:

  • Keeping up to date with changes to pharmacovigilence and drug safety regulations in Asia and worldwide
  • Ensuring effective pharmacovigilance in clinical trials and in the post-marketing of drugs and devices
  • The heterogeneity of safety requirements and pharmacovigilance systems in Asia and how Asia can move towards achieving a harmonized safety data exchange system
  • What can be done to combat drug counterfeiting and to minimize the impact of substandard pharmaceuticals on drug safey and pharmacovigilance in Asia?
  • Risk management and risk communication of ADE/ADR/SAE reporting

Plus! 2 Focused Workshops!

Workshop A: Preparing for a Pharmacovigilance Inspection .
Workshop B: Risk Management and Ethnicity in Asia - the effect of the complex ethnicity of Asian populations on safety data (featuring guest facilitator – Dr. Edison Liu, President, Human Genome Organisation)

Sponsor Media Partners
MedHimalayas media

[ Register Now ]